Paul Tudor Jones Haemonetics Corp Transaction History
Tudor Investment Corp Et Al
- $29 Billion
- Q1 2025
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Haemonetics Corp stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 19,598 shares of HAE stock, worth $1.06 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,598Holding current value
$1.06 Million% of portfolio
0.0%Shares
14 transactions
Others Institutions Holding HAE
# of Institutions
352Shares Held
53.2MCall Options Held
653KPut Options Held
304K-
Black Rock Inc. New York, NY5.96MShares$322 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$275 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY4.35MShares$235 Million0.24% of portfolio
-
Wellington Management Group LLP Boston, MA2.62MShares$142 Million0.03% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.2MShares$119 Million0.09% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $2.77B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...